New topical drug development in atopic dermatitis: a place for hope

C Paul¹

Affiliations

Comment

C Paul. Br J Dermatol. 2012 Apr.

. 2012 Apr;166(4):711.

doi: 10.1111/j.1365-2133.2012.10913.x.

C Paul¹

¹ Paul Sabatier University, Department of Dermatology, Toulouse, France. paul.c@chu-toulouse.fr

No abstract available

Comment on

Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial.
Bissonnette R, Poulin Y, Zhou Y, Tan J, Hong HC, Webster J, Ip W, Tang L, Lyle M. Bissonnette R, et al. Br J Dermatol. 2012 Apr;166(4):853-60. doi: 10.1111/j.1365-2133.2011.10775.x. Epub 2012 Mar 14. Br J Dermatol. 2012. PMID: 22182053 Clinical Trial.